health economics and outcomes research

News

Economic, Clinical Burden of AML Treatment Episodes in Commercially Insured Patients

07/02/2020

A new retrospective analysis highlights a “substantial economic burden” associated with key acute myeloid leukemia (AML) treatment episodes in commercially insured patients. Results of the analysis were published in...

A new...

07/02/2020

Journal of Clinical Pathways

Research Reports

Costs of Care for Patients Receiving Chemotherapy for Advanced Bladder Cancer

12/13/2017

Xiting Cao , PhD;

Amishi Y. Shah , MD;

Yichen Zhong , MPH;

Ashish M. Kamat , MD, MBBS;

Kyle Flannery , PharmD, MS;

Jinghua He , PhD, MPH;

12/13/2017

Journal of Clinical Pathways

Research in Review

Costs and Complications Associated With Repeated Breast-Conserving Surgery for Breast Cancer

08/09/2017

JCP Editors

More than 23% of patients with breast cancer who undergo breast-conserving surgery followed by subsequent surgery do not receive the full benefits of surgery due to added costs and complications, according...

More...

08/09/2017

Journal of Clinical Pathways

Research in Review

Cost-Effectiveness of Multiple Myeloma Therapies From a Payer‚Äôs Perspective

08/02/2017

JCP Editors

A recent cost-effectiveness analysis compared novel agents and chemotherapy for older Medicare patients with multiple myeloma, published in the Journal of Managed Care & Specialty Pharmacy (August...

A...

08/02/2017

Journal of Clinical Pathways

Research in Review

Clinical Trial Efficacy Consistent with Real-World Outcomes, Study Shows

07/28/2017

JCP Editors

Researchers compared the relationship between randomized controlled clinical trial efficacy data and real-world effectiveness for oncology therapies, published in Value in Health (July-August,...

...

07/28/2017

Journal of Clinical Pathways

Research in Review

Distress Screening Adherence Results in Less Medical Resource Utilization, Cost Savings

07/25/2017

JCP Editors

Adherence to distress screening protocols could lead to 18% fewer ER visits and 19% fewer hospitalizations, according to a recent study published in Journal of the National Comprehensive Cancer Network (July...

...

07/25/2017

Journal of Clinical Pathways

Research in Review

Comparing Prognostic Values of MRI or PET-CT at Multiple Myeloma Diagnosis

07/12/2017

JCP Editors

Researchers identified which imaging technique is better for evaluating prognosis of newly-diagnosed multiple myeloma, published in the Journal of Clinical Oncology (published online July 7, 2017;...

...

07/12/2017

Journal of Clinical Pathways

Research in Review

Post-Surgery Complications for Gastric Cancer Significantly Raise Hospital Costs

06/29/2017

JCP Editors

Major complications following total gastrectomy for gastric adenocarcinoma can triple the amount of standard hospital costs, according to research published in JAMA Surgery (published online June 28, 2017;...

Major...

06/29/2017

Journal of Clinical Pathways

Research in Review

Intensified Regimens More Effective Than Standard Therapy in DLBCL

06/28/2017

JCP Editors

Intensified regimens improve event-free survival (EFS) and overall survival (OS) in patients newly diagnosed with diffuse large B-cell lymphoma (DLBCL) compared with standard therapy, according to research presented...

...

06/28/2017

Journal of Clinical Pathways

Research in Review

Cost-Effective Substitute for Breast Cancer MRI Identified

06/26/2017

JCP Editors

A recent analysis reports a cost-effective alternative modality that demonstrates similar efficacy to traditional breast magnetic resonance imaging (MRI), published in the American Journal of Roentgenology (June...

A...

06/26/2017

Journal of Clinical Pathways